Evidence map›Paper›PMID 28672782›Full record

ReviewAntioxidants (Basel, Switzerland)2017

Vitamin E and Alzheimer's Disease-Is It Time for Personalized Medicine?

Breana Cervantes, Lynn M Ulatowski

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Enjoy Carefully: The Multifaceted Role of Vitamin E in Neuro-Nutrition.International journal of molecular sciences · 2021
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Effectiveness of Vitamin E Treatment in Alzheimer's Disease.International journal of molecular sciences · 2019
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Dietary Antioxidants and Health Promotion.Antioxidants (Basel, Switzerland) · 2018
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Breana CervantesUrsuline College, Pepper Pike, OH 44121, USA. breana.cervantes@ursuline.edu.
Lynn M UlatowskiUrsuline College, Pepper Pike, OH 44121, USA. lynn.ulatowski@ursuline.edu.
Ursuline College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For the last two decades, it has been hotly debated whether vitamin E-the major lipid-soluble antioxidant, which functions to maintain neurological integrity-is efficacious as a therapy for Alzheimer's disease. Several factors key to the debate, include (1) which of the eight naturally-occurring vitamin E forms should be used; (2) how combination treatments affect vitamin E efficacy; and (3) safety concerns that most-recently resurfaced after the results of the Selenium and vitamin E Cancer prevention trial SELECT prostate cancer trial. However, with the advent of new genetic technologies and identifications of vitamin E-modulating single nucleotide polymorphisms (SNPs), we propose that clinical trials addressing the question "Is vitamin E an effective treatment for Alzheimer's disease" should consider a more focused and personalized medicine approach to designing experiments. An individual's naturally-occurring SNP variants may indeed influence vitamin E's therapeutic effect on Alzheimer's disease.

Indexed as

Alzheimer’s diseaseoxidative stresspersonalized medicineSNPsvitamin E

Identifiers

PMID28672782
PMCPMC5618073
OpenAlexW2646442462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.